寶業集團(02355.HK)中期淨利3.35億元 同比增加12.54%
格隆匯8月27日丨寶業集團(02355.HK)公吿,截至2021年6月30日止6個月,公司營業額131.15億元人民幣,同比增加17.07%;公司擁有人應占淨利潤3.35億元,同比增加12.54%;每股盈利0.60元。董事會決議不派發截至2021年6月30日止6個月中期股息(2020年同期:零)。
期內,疫情防控形勢依然嚴峻,但經過2020年武漢一役,在疫情防控與儘量維護正常的經濟社會秩序、努力保持生產生活平穩有序方面,積累了豐富的經驗。集團一方面切實加強疫情防控,一絲不苟落實各項疫情防控措施,一方面有序安排各項生產經營,各項經營指標較去年同期基本保持穩定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.